Moreover, alteration at the level of mTOR activity promotes the invasiveness and metastatic potential in a variety of malignancies such as glioblastoma, small cell lung cancer, osteosarcoma, pancreatic cancer, leukemia, breast, colon cancer and RCC [9]. The gene discussed is MTOR; the disease is renal cell carcinoma.